Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Vaccine development

Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials

Wendy Stevens, Anatoli Kamali, [ ... ], Nzeera Ketter

Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial

Anna H. Roukens, Ann C. Vossen, [ ... ], Leo G. Visser

ESAT-6/CFP10 Skin Test Predicts Disease in M. tuberculosis-Infected Guinea Pigs

Karin Weldingh, Peter Andersen

Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults

Jinhong Hu, Zhihui Chen, [ ... ], Weiqing Pan

High Genetic Stability of Dengue Virus Propagated in MRC-5 Cells as Compared to the Virus Propagated in Vero Cells

Chia-Chyi Liu, Shiang-Chi Lee, Michael Butler, Suh-Chin Wu

Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine

Isabel Leroux-Roels, Roger Bernhard, [ ... ], Geert Leroux-Roels

Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children

Alassane Dicko, Issaka Sagara, [ ... ], Ogobara K. Doumbo

Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein

Aric L. Gregson, Giane Oliveira, [ ... ], Robert Edelman

Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial

Fiona M. Thompson, David W. Porter, [ ... ], Adrian V. S. Hill

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

Mahamadou A. Thera, Ogobara K. Doumbo, [ ... ], Christopher V. Plowe

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine

Benoît Baras, Koert J. Stittelaar, [ ... ], Albert D. M. E. Osterhaus

A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial

Shinji L. Okitsu, Olivier Silvie, [ ... ], Gerd Pluschke

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

Ansar A. Pathan, Clare R. Sander, [ ... ], Helen McShane

Advertisement

Create a weekly email alert for: Vaccine development

You can change these options by clicking profile then "Alerts and Notifications"